Embedded supportive care programs deliver measurable improvements, but fee-for-service economics prevent scaling because ...

Midterm messaging is likely to center on health care costs, with Republicans emphasizing DTC drug models and MFN pricing ...

Esketamine first received FDA approval in 2019, but with an important restriction: it could only be used in combination with an oral antidepressant. That requirement, built into the original label and ...

John Barkett, MBA, discusses recent regulatory proposals to make massive health plan price files more usable. Price ...

Tim Church, MD, PhD, MPH, explains that access to care—not willpower—is the central barrier to GLP-1 use, and says employer ...

Reproxalap was found to be safe to take in patients diagnosed with dry eye disease (DED), as no serious treatment-emergent adverse events (TEAEs) were reported in patients taking the medication. These ...

Shawn Davis, MD, discusses what access and policy changes are needed to close the coverage gap. Glucagon-like peptide-1 ...

Amy Leader, DrPH, MPH, explains that trust is key to clinical trial enrollment at an Institute for Value-Based Medicine event in Philadelphia. Leader said many large cancer centers are working more ...

Genome-first analyses in UK Biobank and All of Us support RBM20 as an arrhythmogenic DCM gene, with an etiologic fraction of ...

Amy Leader, DrPH, MPH, explains that trust is key to clinical trial enrollment at an Institute for Value-Based Medicine event in Philadelphia. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...

As cell and gene therapies (CGTs) continue to receive regulatory approvals at an accelerating pace, health care institutions ...

An Excel-based actuarial model (1 million lives; 49% eligible; 10% treated) estimated semaglutide coverage could be ...